cns.jpg (2811 bytes)



Journal Home
Editorial Board
Instructions for Contributors
Subscription Rates

Neva Press, Inc. 2005

CNS Drug Reviews

Table of Contents

Volume 5, No. 1

1 LY354740:  A Systemically Active mGlu2/mGlu3 Receptor Agonist
Darryle D. Schoepp, James A. Monn, Gerard J. Marek, George Aghajanian and Bita Moghaddam
13 Metrifonate:   A Cholinesterase Inhibitor for Alzheimer's Disease Therapy
Lon S. Schneider and Ezio Giacobini
27 ()-18-Methoxycoronaridine:   A Novel Iboga Alkaloid Congener Having Potential Anti-Addictive Efficacy
Stanley D. Glick, Isabelle M. Maisonneuve, Lindsay B. Hough, Martin E. Kuehne and Upul K. Bandarage
43 The Pharmacology of SR 141716A:  A Review
E. M. Nakamura-Palacios, J. M. Moerschbaecher and L. A. Barker
Meeting Reports
59 Melatonin after Four Decades:  An Assessment of Its Potential.  Hamburg, Germany.  August 11-19, 1998.
James Olcese
64 Inflamed Brains:  Neuroimmune Interactions in Diseases of the Nervous System.  Fondation IPSEN, Paris, France.  October 5, 1998.
Jennifer Altman
70 Fourth Hungarian Conference on Alzheimer's Disease and Related Disorders.  Szeged, Hungary. October 7-9, 1998.
Peter Kasa
77 Estrogen Actions in the Brain:  A Symposium to Honor the Contributions of Roger A. Gorski.   University of California, Los Angeles.  November 6, 1998.
Catherine Priest and Paul Micevych
83 Fourth Annual Promega Neurosciences Symposium:  Genetic and Environmental Interactions in Neurodegeneration.  Los Angeles, CA.  November 7, 1998.
Neil Cosby and Mary Haak-Frendscho
91 Errata